{"url_path":"/sec/bblgw/10-q/2026/item-1a","section_key":"item-1a","section_title":"Item 1A Risk Factors.**","topic":"sec","document":{"doc_type":"10-Q","doc_date":"2026-05-14","source_url":"https://www.sec.gov/Archives/edgar/data/1419554/0001493152-26-023163-index.html","accession_number":"0001493152-26-023163","cik":"0001419554","ticker":"BBLG","issuer_name":"Bone Biologics Corp","edgar_url":"https://www.sec.gov/Archives/edgar/data/1419554/0001493152-26-023163-index.html","primary_entity_key":"0001419554","primary_entity_name":"Bone Biologics Corp"},"word_count":99,"has_tables":true,"body_markdown":"**Item\n1A. Risk Factors.**\n\n \n\nFor\na discussion of the Company’s potential risks or uncertainties, please see “Part I—Item 1A—Risk Factors”\nand “Part II—Item 7—Management’s Discussion and Analysis of Financial Condition and Results of Operations”\nin the Company’s Annual Report on Form 10-K for the year ended December 31, 2025, filed with the SEC, and “Part I—Item\n2—Management’s Discussion and Analysis of Financial Condition and Results of Operations” herein. There have been no\nmaterial changes from the risk factors as previously disclosed in our Annual Report on Form 10-K for the year ended December 31, 2025\nexcept as noted herein."}